A bloodspot test shall screen for
the following congenital disorders:
1.
3-Hydroxy-3-methylglutaric aciduria,
2.
3-Methylcrotonyl-CoA carboxylase
deficiency,
3.
Argininosuccinic acidemia,
4.
Beta-ketothiolase deficiency,
5.
Biotinidase deficiency,
6.
Carnitine uptake defect,
7.
Citrullinemia,
8.
Classic galactosemia,
9.
Congenital adrenal hyperplasia,
10.
Congenital hypothyroidism,
11.
Cystic fibrosis,
12.
Glutaric acidemia type I,
13.
Hemoglobin S/Beta-thalassemia,
14.
Hemoglobin S/C disease,
15.
Homocystinuria,
16.
Isovaleric acidemia,
17.
Long-chain 3-hydroxy acyl-CoA dehydrogenase
deficiency,
18.
Maple syrup urine disease,
19.
Medium chain acyl-CoA dehydrogenase
deficiency,
20.
Methylmalonic acidemia (Cbl A,B),
21.
Methylmalonic acidemia (mutase
deficiency),
22.
Multiple carboxylase deficiency,
23.
Phenylketonuria,
24.
Propionic acidemia,
25.
Sickle cell anemia,
26.
Trifunctional protein deficiency,
27.
Tyrosinemia type I, and
28.
Very long-chain acyl-CoA dehydrogenase
deficiency.
A. A health care
facility's designee, a health care provider, or a health care provider's
designee shall order critical congenital heart defect screening using pulse
oximetry for a newborn to be performed:
1.
Between 24 and 48 hours after birth according to the health care facility's or
health care provider's policies and procedures, or
2. As late as possible before discharge
according to the health care facility's or health care provider's policies and
procedures if the newborn is discharged earlier than 24 hours after
birth.
B. Before
critical congenital heart defect screening is performed on a newborn, a health
care facility's designee, a health care provider, or a health care provider's
designee shall provide educational materials to the newborn's parent or
guardian.
C. When critical
congenital heart defect screening is ordered for a newborn, a health care
facility's designee, a health care provider, or a health care provider's
designee shall submit, in a format specified by the Department, the following
information:
1. The newborn's name, gender,
race, ethnicity, medical record number, and, if applicable, AHCCCS
identification number;
2. Whether
the newborn is from a single or multiple birth;
3. If the newborn is from a multiple birth,
the birth order of the newborn;
4.
The date and time of birth, and the newborn's weight at birth;
5. The identification code or the name and
address of the health care facility or health care provider submitting the
information;
6. Except as provided
in subsection (C)(7), the mother's first and last names, date of birth, name
before first marriage, mailing address, telephone number, and, if applicable,
AHCCCS identification number;
7. If
the newborn's mother does not have physical custody of the newborn, the first
and last names, mailing address, and telephone number of the person who has
physical custody of the newborn;
8.
The date, time, and result of the critical congenital heart defect
screening;
9. If critical
congenital heart defect screening was not performed, the reason critical
congenital heart defect screening was not performed;
10. If the newborn was transferred to another
health care facility or health care provider before the critical congenital
heart defect screening was performed, the name, address, and telephone number
of the health care facility or health care provider to which the newborn was
transferred; and
11. Whether the
newborn has a medical condition that may affect the critical congenital heart
defect screening results.
D. In addition to the information in
subsection (C), if the reported result of critical congenital heart defect
screening for a newborn or infant is abnormal, a health care facility's
designee, a health care provider, or a health care provider's designee shall
submit to the Department, upon request and in a format specified by the
Department, the following information:
1. The
dates, times, values of all critical congenital heart defect screening
results;
2. The dates, times, and
results of any subsequent tests performed as a result of critical congenital
heart defect screening;
3. The
name, address, and telephone number of the contact person for the health care
facility, health care provider, or other person performing the subsequent
tests; and
4. If a medical
condition is found as a result of critical congenital heart defect screening or
subsequent tests, the type of medical condition found and the name of the
health care provider who will be responsible for the coordination of medical
services for the newborn or infant after the newborn or infant is
discharged.
